Stewart D. Chipman

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

DiaKine Therapeutics, Inc. is a start-up biopharmaceutical company developing new, proprietary drugs for unmet medical needs in diabetes and complications related to diabetes. These drugs have the potential to restate the diabetes market by stopping the progression of diabetes and reversing damage already caused by the disease. Because of their unique immune modulating and anti-inflammatory properties, these therapies may potentially benefit people with type 1 and type 2 diabetes and represent a total available market opportunity of approximately $13 billion. The Company's lead compound, Lisofylline (LSF), has had an excellent safety profile in clinical trials to date. LSF works at the cellular level by improving the function of insulin producing islet cells and protecting them from damage and premature death caused when the body's immune system turns on itself. This autoimmune action is the cause of type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA), which combined affect approximately three million people in the U.S. About three million people with type 2 diabetes use insulin due to diminished insulin production and an increasing resistance to insulin. A primary focus of DiaKine's research and development is on its next generation of orally bioavailable immune modulators which have an improved spectrum of action to LSF. Two such compounds, DT22669 and DT23552, have been identified for further development and are examples of the extensive library of analogs and new structures in its patent portfolio that await discovery for future indications.

Cytogel Pharma LLC develops bio-pharmaceutical products. It offers novel analgesic products, useful polymer and hydrogel drug delivery platform technologies. The company was founded in 2002 and is headquartered in Darien, CT.

Fe3 Medical, Inc. develops a transdermal therapy for iron deficiency anemia. It offers a disposable transdermal patch that delivers the amount of iron needed directly through the skin, bypassing the GI tract and eliminating undesirable side effects. The company was founded by Mir A. Imran in 2008 and is headquartered in San Antonio, TX.

KitoTech Medical, Inc. operates as a medical device company which develops medical products based on its proprietary micro staple technology platform. It specializes in wound closure, patient care, emergency laceration, surgery, skin closure device, and biotechnology. The company was founded by Ronald J. Berenson and Marco Rolandi in 2013 and is headquartered in Seattle, WA.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

ORBIS International, Inc. prevents and treats blindness by providing eye care to transform lives. It offers tools, training and technology necessary for local partners to develop eye care services. The company was founded in 1982 by David Paton and is headquartered in New York, NY.

Veterans Administration Medical Center provides healthcare services. The private company is based in San Diego, CA.

March of Dimes Foundation is a non-profit organization for pregnancy and baby health. The organization works to improve the health of babies by preventing birth defects, premature birth, and infant mortality. March of Dimes Foundation was founded on January 3, 1938 and is headquartered in Arlington, VA.

Part of The Conference Board, Inc., Committee for Economic Development is a nonprofit, nonpartisan, business-led organization that delivers well-researched analysis and reasoned solutions in the nation's interest. The company is based in New York, NY. The company's trustees, who are chief executive officers and key executives of leading US companies, bring their unique experience to address pressing policy issues. The company collectively represents 30+ industries, over a trillion dollars in revenue, and over 4 million employees. Founded in 1942, the organization uses cookies to improve their website and offers products and services to enhance user experience. Committee for Economic Development was acquired by The Conference Board, Inc. on January 14, 2015.

Alliance for Aging Research operates as a national citizen advocacy organization. It also advocates and implements health education for consumers and health professionals. The company was founded by Daniel Perry in 1986 and is headquartered in Washington, DC.

Part of Eisai Co., Ltd., Eisai Corp. of North America is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Woodcliff Lake, NJ.

Smithsonian National Air & Space Museum operates museums. The company was founded in 1976 and is headquartered in Washington, DC.

ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer.

Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA.

New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA.

United Hospital Fund is a non-profit organization which organizes charitable support for voluntary, nonprofit hospitals. It offers Improving Health Care for Every New Yorker, tribute gifts, memorial gifts, planned giving, and special events. The organization was founded in 1879 and is headquartered in New York, NY.

Experimental Aircraft Association, Inc. provides advice and support services to aviation industry. It also participates in the flying, building, and restoring of recreational aircrafts. The company was founded by Paul H. Poberezny on January 26, 1953 and is headquartered in Oshkosh, WI.

Rivkin Center for Ovarian Cancer is a non-profit organization that funds ovarian cancer research, screening, and educational programs for women. The company was founded by Saul E. Rivkin in 1996 and is headquartered in Seattle, WA.

The Seattle Symphony Orchestra provides music entertainment. The private company is based in Seattle, WA.

DMD Therapeutics, Inc. develops novel therapeutics for DMD and other muscular dystrophies. The company was founded by Carlo Rago and Ronald Berenson in 2016 and is headquartered in Seattle, WA.

Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA.

TuHURA Biopharma, Inc. operates as a biotechnology company. It develops bifunctional immunoconjugates for the treatment of cancer. The company was founded in 2018 and is headquartered in Seattle,WA.